Phase I, Open Labeled, Dose Escalation trial in healthy male subjects to examine the Pharmacokinetics, Pharmacodynamics, and safety of single dose usage of F-627
Latest Information Update: 27 Apr 2021
At a glance
- Drugs Efbemalenograstim alfa (Primary)
- Indications Neutropenia
- Focus Adverse reactions
Most Recent Events
- 07 Jan 2015 New trial record